Oxford Science Enterprises

Founded in 2015, Oxford Science Enterprises is a venture firm that partners with the University of Oxford to build science-based businesses. It invests primarily in life sciences, AI and software, healthcare, and deep tech sectors, aiming to create companies capable of addressing global challenges such as infectious diseases and nuclear fusion.

Claire Brown

Partner, Life Sciences

Liliane Chamas Ph.D

Principal

Sally Dewhurst Ph.D

Principal, Life Sciences

Nicholas Dixon-Clegg

Principal

Sam Harman

Senior Investment Associate

Past deals in Laser

Oxford Endovascular

Series A in 2024
Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.

Archangel Lightworks

Seed Round in 2023
Archangel Lightworks is a laser communications company specializing in the development of secure, wireless technology aimed at addressing the challenges of space-ground connectivity. The company focuses on creating innovative laser transmission systems that facilitate efficient communication within the aerospace sector. Its product offerings include space terminals designed for satellites, air terminals for drones and manned aircraft, and ground communications terminals. By providing these advanced solutions, Archangel Lightworks enables resilient connectivity that overcomes the limitations of traditional radio communications, which are often bandwidth-constrained and less secure.

Opsydia

Venture Round in 2022
Opsydia Limited, established in 2017 and based in Begbroke, UK, specializes in manufacturing advanced laser marking technology. This technology enables the creation of permanent, invisible structures such as serial numbers, images, and cryptographic data within transparent materials like diamonds, glass, polymers, and plastics without altering their surface or integrity. Opsydia's innovative solution aims to disrupt various industries by enhancing security, traceability, and authenticity in transparent materials.

Oxford Endovascular

Series A in 2021
Oxford Endovascular develops a neurovascular device to treat brain aneurysms. The device uses origami-inspired engineering with a laser-cut metal alloy that has shape-memory, enabling a catheter-delivered implant to expand into a tiny mesh tube that conforms to the vessel. By diverting blood flow away from the aneurysm, it promotes healing and reduces the risk of rupture.

Opsydia

Seed Round in 2018
Opsydia Limited, established in 2017 and based in Begbroke, UK, specializes in manufacturing advanced laser marking technology. This technology enables the creation of permanent, invisible structures such as serial numbers, images, and cryptographic data within transparent materials like diamonds, glass, polymers, and plastics without altering their surface or integrity. Opsydia's innovative solution aims to disrupt various industries by enhancing security, traceability, and authenticity in transparent materials.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.